The WTO waiver battle over Covid jab IP rights
Sudden US backing for a global waiver on patent protections for Covid-19 vaccines offers hope to poor nations struggling for doses -- but big pharma thinks the notion misguided
Pandemic showcases Belgium as Europe’s Vaccine Valley
A small country with an outsize reputation in research and pharmaceuticals, Belgium has emerged with a strategic role in the world's battle against the coronavirus
Vaccine storm engulfs EU chief von der Leyen
EU chief Ursula von der Leyen faces the deepest political crisis of her mandate so far, under intense fire over delayed vaccine deliveries and the bungled roll-out of export controls
Frontrunners emerge in race for Covid-19 vaccine
Positive results from trials of several vaccine candidates have raised hopes that there is light at the end of the tunnel in the quest to curb a pandemic that has already killed 1.4 million
EU executive wants Health Union after fractured pandemic response
The European Commission has suggested forming a new European Health Union in order for all EU member states to collectively fight the COVID-19 Pandemic together.
In race for vaccine, safety trumps speed
The halting of clinical trials for one of the most advanced experimental Covid-19 vaccines shows the importance of safety in developing new medicines, experts say
The hunt for COVID-19 treatment, vaccines
Scientists around the world are scrambling to develop preventative vaccines and therapeutic treatments for COVID-19, with tests into dozens of drugs and hundreds of clinical trials
Multinationals in the time of virus: who wins, who loses?
The coronavirus pandemic, set to provoke a severe global recession this year, is hitting multinational companies disproportionately. But what sectors might succeed during the pandemic?
Medicine shortage looms over coronavirus-hit Europe
While the world waits for a coronavirus vaccine, medicines used to deal with the symptoms of the disease are increasingly in critically short supply in Europe, the worst-hit continent
What no Brexit deal means for ‘Made in Germany’
German business is worried about bottlenecks in cross-Channel supply chains in the event of a hard Brexit.